An enzymatic effect for cancer prevention and eradication
1Hirata Hospital, Kochi City, Japan.
Abstract:
As previously described in a series of hypotheses, cancer development depends on an unconvertable duplication mitosis caused by some abnormal supplement of the mitotic maturation promoting system which is paralyzed in the cancerous cell's cytoplasm. This abnormal supplement, which may be responsible for the cancer's development, must be a biochemical compound that could be eliminated by exposure to the action of certain enzymes. Accordingly, in order to prevent and eradicate cancer development in general, an enzyme which would destroy and eliminate the biochemical supplement needs to be identified, and a specific method of delivering the enzyme to the supplement needs to be devised.
Insights
Cancer develops from an abnormal supplement paralyzing cell division. Identifying an enzyme to destroy this supplement and a delivery method could prevent and eradicate cancer.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Cancer development is hypothesized to stem from an unconvertable duplication mitosis.
- This process is driven by an abnormal supplement within the mitotic maturation promoting system, which is paralyzed in cancer cells.
Purpose of the Study:
- To identify a specific enzyme capable of destroying the proposed biochemical supplement responsible for cancer.
- To devise a method for delivering this enzyme to the target supplement within cancerous cells.
Main Methods:
- This study is based on prior hypotheses and theoretical biochemical pathways.
- The primary method involves conceptualizing the identification and delivery of a cancer-eradicating enzyme.
Main Results:
- The proposed biochemical supplement, if identified, is theorized to be destructible by specific enzymes.
- Successful enzyme identification and delivery could lead to cancer prevention and eradication.
Conclusions:
- A key biochemical compound is hypothesized to drive cancer development by disrupting mitosis.
- The development of a targeted enzyme therapy presents a potential strategy for cancer treatment and prevention.
Related Concept Videos
Mitogens and the Cell Cycle
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...


